Effectiveness of Brief Motivational Interview for Metabolic Abnormalities in Schizophrenia : A Pilot Randomized Controlled Trial

Effectiveness of Brief Motivational Interview to Improve Metabolic Abnormalities in Patients with Schizophrenia and other Primary Psychotic Disorder: A Pilot Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103304

Enrollment

Registered

2026-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F200- Paranoid schizophrenia

Interventions

Intervention1: Brief Motivational Interview: Brief Motivational Interview will be developed and validated after consensus from expert psychiatrist and clinical psychologists. Brief Motivational Interv

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18-60 years diagnosed with schizophrenia and other primary psychotic disorder according to ICD -11 criteria

Exclusion criteria

Exclusion criteria: Presence of co-morbid psychiatric disorders, or organic brain syndromes Presence of co-morbid chronic physical illness except Diabetes, Hypertension and Dyslipidemia

Design outcomes

Primary

Measure	Time frame
Changes in Metabolic parameter: change in weight, BMI, waist circumference, blood pressure, lipid profile, S. Insulin and fasting blood glucose.Timepoint: 1 month 2 month 3 month 6 month	—

Secondary

Measure	Time frame
Well-being of patients: Measured using the WHO-5. Functional Status: Assessed by the Global Assessment of Functioning (GAF) scale Level of physical activity Timepoint: 1 month 2 month 3 month 6 month	—

Countries

India

Contacts

Public ContactVijay Kumar Saini

All India Institute of Medical Sciences (AIIMS), Jodhpur

vsaini344@gmail.com9460869846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026